Pharmacogenomics (PGx) is a foundational component of precision medicine, yet many laboratories and health systems continue to face challenges translating PGx evidence into routine clinical workflows.
EDMONTON, ALBERTA--(Marketwired - Feb. 3, 2016) - Ceapro Inc. (TSX VENTURE:CZO) ("Ceapro" or the "Company"), a growth-stage biotechnology company focused on the development and commercialization of ...
EDMONTON, Alberta, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results